BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36093405)

  • 21. The influences of peritumoral lymphatic invasion and vascular invasion on the survival and recurrence according to the molecular subtypes of breast cancer.
    Hwang KT; Kim YA; Kim J; Chu AJ; Chang JH; Oh SW; Hwang KR; Chai YJ
    Breast Cancer Res Treat; 2017 May; 163(1):71-82. PubMed ID: 28194538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective analysis of concurrent docetaxel and epirubicin neoadjuvant versus adjuvant chemotherapy: Which leads to better outcomes for different subtype breast cancer patients?
    Yang H; Zhou L; Wang S; Cao Y; Tong F; Liu P; Zhou B; Cheng L; Liu M; Liu H; Xie F; Guo J; Wang S; Peng Y
    Medicine (Baltimore); 2018 Oct; 97(40):e12690. PubMed ID: 30290661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study.
    Su Y; Zheng Y; Zheng W; Gu K; Chen Z; Li G; Cai Q; Lu W; Shu XO
    BMC Cancer; 2011 Jul; 11():292. PubMed ID: 21749714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct outcomes in patients with different molecular subtypes of inflammatory breast cancer.
    Zhou J; Yan Y; Guo L; Ou H; Hai J; Zhang C; Wu Z; Tang L
    Saudi Med J; 2014 Nov; 35(11):1324-30. PubMed ID: 25399208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.
    Poorolajal J; Nafissi N; Akbari ME; Mahjub H; Esmailnasab N; Babaee E
    Arch Iran Med; 2016 Oct; 19(10):680-686. PubMed ID: 27743431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients.
    Engstrøm MJ; Opdahl S; Hagen AI; Romundstad PR; Akslen LA; Haugen OA; Vatten LJ; Bofin AM
    Breast Cancer Res Treat; 2013 Aug; 140(3):463-73. PubMed ID: 23901018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival.
    Lee JA; Kim KI; Bae JW; Jung YH; An H; Lee ES;
    Breast Cancer Res Treat; 2010 Aug; 123(1):177-87. PubMed ID: 20574671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Family history of cancer other than breast or ovarian cancer in first-degree relatives is associated with poor breast cancer prognosis.
    Song JL; Chen C; Yuan JP; Li JJ; Sun SR
    Breast; 2017 Apr; 32():130-134. PubMed ID: 28178607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis.
    Gong Y; Zhang J; Ji P; Ling H; Hu X; Shao ZM
    Cancer Med; 2018 Aug; 7(8):4156-4169. PubMed ID: 29984914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?
    Sheridan W; Scott T; Caroline S; Yvonne Z; Vanessa B; David V; Karen G; Stephen C
    Breast Cancer Res Treat; 2014 Oct; 147(3):617-29. PubMed ID: 25209005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival.
    Inwald EC; Koller M; Klinkhammer-Schalke M; Zeman F; Hofstädter F; Gerstenhauer M; Brockhoff G; Ortmann O
    Breast Cancer Res Treat; 2015 Oct; 153(3):647-58. PubMed ID: 26369534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
    Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
    Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MMP-1 expression has an independent prognostic value in breast cancer.
    Boström P; Söderström M; Vahlberg T; Söderström KO; Roberts PJ; Carpén O; Hirsimäki P
    BMC Cancer; 2011 Aug; 11():348. PubMed ID: 21835023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
    He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
    Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance.
    Kim HK; Park KH; Kim Y; Park SE; Lee HS; Lim SW; Cho JH; Kim JY; Lee JE; Ahn JS; Im YH; Yu JH; Park YH
    Cancer Res Treat; 2019 Apr; 51(2):737-747. PubMed ID: 30189722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
    Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA
    Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term survival analysis of different breast cancer molecular subtypes: Shanghai Breast Cancer Survival Study].
    Bao P; Peng P; Gu K; Wu C; Huang Z; Gong Y; Zhang M; Zheng Y
    Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):928-34. PubMed ID: 26850665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
    Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
    J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between molecular type and prognosis of patients with stage IV breast cancer: an observational study based on SEER database.
    Hou L; Qiu M; Chen M; Li F; Li J; Deng S; Yang Y; Du Z; Yang H
    Gland Surg; 2021 Jun; 10(6):1889-1898. PubMed ID: 34268073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.